MENU
NKTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nkarta (NKTX) Ownership - Who owns Nkarta?

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies... Show more

Profile

Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
108
Web
https://www.nkartatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
171.71M
P/E Ratio
N/A
Total Cash
230.43M
Projected Growth
N/A
Total Debt
75M
Revenue
N/A
Risk (Beta)
2.27
Dividend Yield
N/A
Total Cash/Share
3.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
NKTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
108
Web
https://www.nkartatx.com